Global Afatinib Market Professional Survey Report 2018

March 2018 | 105 pages | ID: G6964B02073QEN
QYResearch

Abstracts

This report studies Afatinib in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Boehringer Ingelheim
• Teva Pharmaceutical Industries
• Myosynth
• Reva Pharma
• Tianjin Scipharmacn
• Hubei Purple Sakura Chemical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• ?98%
• ?98%

By Application, the market can be split into

• Non-Small Cell Lung Cancer
• Application 2

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Afatinib Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF AFATINIB

1.1 Definition and Specifications of Afatinib
  1.1.1 Definition of Afatinib
  1.1.2 Specifications of Afatinib
1.2 Classification of Afatinib
  1.2.1 ?98%
  1.2.2 ?98%
1.3 Applications of Afatinib
  1.3.1 Non-Small Cell Lung Cancer
  1.3.2 Application
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF AFATINIB

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Afatinib
2.3 Manufacturing Process Analysis of Afatinib
2.4 Industry Chain Structure of Afatinib

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF AFATINIB

3.1 Capacity and Commercial Production Date of Global Afatinib Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Afatinib Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Afatinib Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Afatinib Major Manufacturers in 2017

4 GLOBAL AFATINIB OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Afatinib Capacity and Growth Rate Analysis
  4.2.2 2017 Afatinib Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Afatinib Sales and Growth Rate Analysis
  4.3.2 2017 Afatinib Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Afatinib Sales Price
  4.4.2 2017 Afatinib Sales Price Analysis (Company Segment)

5 AFATINIB REGIONAL MARKET ANALYSIS

5.1 North America Afatinib Market Analysis
  5.1.1 North America Afatinib Market Overview
  5.1.2 North America 2013-2018E Afatinib Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Afatinib Sales Price Analysis
  5.1.4 North America 2017 Afatinib Market Share Analysis
5.2 China Afatinib Market Analysis
  5.2.1 China Afatinib Market Overview
  5.2.2 China 2013-2018E Afatinib Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Afatinib Sales Price Analysis
  5.2.4 China 2017 Afatinib Market Share Analysis
5.3 Europe Afatinib Market Analysis
  5.3.1 Europe Afatinib Market Overview
  5.3.2 Europe 2013-2018E Afatinib Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Afatinib Sales Price Analysis
  5.3.4 Europe 2017 Afatinib Market Share Analysis
5.4 Southeast Asia Afatinib Market Analysis
  5.4.1 Southeast Asia Afatinib Market Overview
  5.4.2 Southeast Asia 2013-2018E Afatinib Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Afatinib Sales Price Analysis
  5.4.4 Southeast Asia 2017 Afatinib Market Share Analysis
5.5 Japan Afatinib Market Analysis
  5.5.1 Japan Afatinib Market Overview
  5.5.2 Japan 2013-2018E Afatinib Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Afatinib Sales Price Analysis
  5.5.4 Japan 2017 Afatinib Market Share Analysis
5.6 India Afatinib Market Analysis
  5.6.1 India Afatinib Market Overview
  5.6.2 India 2013-2018E Afatinib Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Afatinib Sales Price Analysis
  5.6.4 India 2017 Afatinib Market Share Analysis

6 GLOBAL 2013-2018E AFATINIB SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Afatinib Sales by Type
6.2 Different Types of Afatinib Product Interview Price Analysis
6.3 Different Types of Afatinib Product Driving Factors Analysis
  6.3.1 ?98% of Afatinib Growth Driving Factor Analysis
  6.3.2 ?98% of Afatinib Growth Driving Factor Analysis

7 GLOBAL 2013-2018E AFATINIB SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Afatinib Consumption by Application
7.2 Different Application of Afatinib Product Interview Price Analysis
7.3 Different Application of Afatinib Product Driving Factors Analysis
  7.3.1 Non-Small Cell Lung Cancer of Afatinib Growth Driving Factor Analysis
  7.3.2 Application 2 Afatinib Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF AFATINIB

8.1 Boehringer Ingelheim
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Boehringer Ingelheim 2017 Afatinib Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Boehringer Ingelheim 2017 Afatinib Business Region Distribution Analysis
8.2 Teva Pharmaceutical Industries
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Teva Pharmaceutical Industries 2017 Afatinib Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Teva Pharmaceutical Industries 2017 Afatinib Business Region Distribution Analysis
8.3 Myosynth
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Myosynth 2017 Afatinib Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Myosynth 2017 Afatinib Business Region Distribution Analysis
8.4 Reva Pharma
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Reva Pharma 2017 Afatinib Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Reva Pharma 2017 Afatinib Business Region Distribution Analysis
8.5 Tianjin Scipharmacn
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Tianjin Scipharmacn 2017 Afatinib Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Tianjin Scipharmacn 2017 Afatinib Business Region Distribution Analysis
8.6 Hubei Purple Sakura Chemical
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Hubei Purple Sakura Chemical 2017 Afatinib Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Hubei Purple Sakura Chemical 2017 Afatinib Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF AFATINIB MARKET

9.1 Global Afatinib Market Trend Analysis
  9.1.1 Global 2018-2025 Afatinib Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Afatinib Sales Price Forecast
9.2 Afatinib Regional Market Trend
  9.2.1 North America 2018-2025 Afatinib Consumption Forecast
  9.2.2 China 2018-2025 Afatinib Consumption Forecast
  9.2.3 Europe 2018-2025 Afatinib Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Afatinib Consumption Forecast
  9.2.5 Japan 2018-2025 Afatinib Consumption Forecast
  9.2.6 India 2018-2025 Afatinib Consumption Forecast
9.3 Afatinib Market Trend (Product Type)
9.4 Afatinib Market Trend (Application)

10 AFATINIB MARKETING TYPE ANALYSIS

10.1 Afatinib Regional Marketing Type Analysis
10.2 Afatinib International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Afatinib by Region
10.4 Afatinib Supply Chain Analysis

11 CONSUMERS ANALYSIS OF AFATINIB

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL AFATINIB MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Afatinib
Table Product Specifications of Afatinib
Table Classification of Afatinib
Figure Global Production Market Share of Afatinib by Type in 2017
Figure ?98% Picture
Table Major Manufacturers of ?98%
Figure ?98% Picture
Table Major Manufacturers of ?98%
Table Applications of Afatinib
Figure Global Consumption Volume Market Share of Afatinib by Application in 2017
Figure Non-Small Cell Lung Cancer Examples
Table Major Consumers in Non-Small Cell Lung Cancer
Figure Market Share of Afatinib by Regions
Figure North America Afatinib Market Size (Million USD) (2013-2025)
Figure China Afatinib Market Size (Million USD) (2013-2025)
Figure Europe Afatinib Market Size (Million USD) (2013-2025)
Figure Southeast Asia Afatinib Market Size (Million USD) (2013-2025)
Figure Japan Afatinib Market Size (Million USD) (2013-2025)
Figure India Afatinib Market Size (Million USD) (2013-2025)
Table Afatinib Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Afatinib in 2017
Figure Manufacturing Process Analysis of Afatinib
Figure Industry Chain Structure of Afatinib
Table Capacity and Commercial Production Date of Global Afatinib Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Afatinib Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Afatinib Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Afatinib Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Afatinib 2013-2018E
Figure Global 2013-2018E Afatinib Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Afatinib Market Size (Value) and Growth Rate
Table 2013-2018E Global Afatinib Capacity and Growth Rate
Table 2017 Global Afatinib Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Afatinib Sales (K Units) and Growth Rate
Table 2017 Global Afatinib Sales (K Units) List (Company Segment)
Table 2013-2018E Global Afatinib Sales Price (USD/Unit)
Table 2017 Global Afatinib Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Afatinib 2013-2018E
Figure North America 2013-2018E Afatinib Sales Price (USD/Unit)
Figure North America 2017 Afatinib Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Afatinib 2013-2018E
Figure China 2013-2018E Afatinib Sales Price (USD/Unit)
Figure China 2017 Afatinib Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Afatinib 2013-2018E
Figure Europe 2013-2018E Afatinib Sales Price (USD/Unit)
Figure Europe 2017 Afatinib Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Afatinib 2013-2018E
Figure Southeast Asia 2013-2018E Afatinib Sales Price (USD/Unit)
Figure Southeast Asia 2017 Afatinib Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Afatinib 2013-2018E
Figure Japan 2013-2018E Afatinib Sales Price (USD/Unit)
Figure Japan 2017 Afatinib Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Afatinib 2013-2018E
Figure India 2013-2018E Afatinib Sales Price (USD/Unit)
Figure India 2017 Afatinib Sales Market Share
Table Global 2013-2018E Afatinib Sales (K Units) by Type
Table Different Types Afatinib Product Interview Price
Table Global 2013-2018E Afatinib Sales (K Units) by Application
Table Different Application Afatinib Product Interview Price
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2017 Boehringer Ingelheim Afatinib Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Boehringer Ingelheim Afatinib Business Region Distribution
Table Teva Pharmaceutical Industries Information List
Table Product A Overview
Table Product B Overview
Table 2017 Teva Pharmaceutical Industries Afatinib Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Teva Pharmaceutical Industries Afatinib Business Region Distribution
Table Myosynth Information List
Table Product A Overview
Table Product B Overview
Table 2015 Myosynth Afatinib Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Myosynth Afatinib Business Region Distribution
Table Reva Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2017 Reva Pharma Afatinib Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Reva Pharma Afatinib Business Region Distribution
Table Tianjin Scipharmacn Information List
Table Product A Overview
Table Product B Overview
Table 2017 Tianjin Scipharmacn Afatinib Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Tianjin Scipharmacn Afatinib Business Region Distribution
Table Hubei Purple Sakura Chemical Information List
Table Product A Overview
Table Product B Overview
Table 2017 Hubei Purple Sakura Chemical Afatinib Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Hubei Purple Sakura Chemical Afatinib Business Region Distribution
Figure Global 2018-2025 Afatinib Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Afatinib Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Afatinib Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Afatinib Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Afatinib Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Afatinib Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Afatinib Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Afatinib Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Afatinib Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Afatinib by Type 2018-2025
Table Global Consumption Volume (K Units) of Afatinib by Application 2018-2025
Table Traders or Distributors with Contact Information of Afatinib by Region